Related Tags >> FDA antibiotic Sanofi Drug Trials

Ketek News

Most Popular Ketek Story

FDA criticizes Aventis for Ketek study failures

October 25, 2007 — 5:59am ET

Aventis allowed a clinical trial of Ketek to proceed uncorrected despite its own audits that revealed "serious protocol violations and regulatory noncompliance by multiple clinical Read more...

Latest Headlines

ALSO NOTED: Lentigen moves to Gaithersburg; Acorda prices shares; Cytheris releases data; and much more...
February 13, 2008
FDA criticizes Aventis for Ketek study failures
October 25, 2007
SPOTLIGHT: FDA panel votes to restrict Ketek
December 17, 2006
ALSO NOTED: FDA staffers back Ketek; Abbott gains a majority of Kos shares; and much more...
December 12, 2006
Senate confirms von Eschenbach as chief of FDA
December 7, 2006
FDA's showdown with Grassley to delay nomination
November 30, 2006
FDA whistle-blower attacks safety of Arcoxia
September 12, 2006
New warnings added to controversial antibiotic
June 29, 2006
FDA reviews new rules for clinical trials
June 20, 2006
Senator makes dramatic demand in Ketek probe
June 14, 2006
ALSO NOTED: DrugAbuse Science to raise $25.2M in an IPO; Covance inks a $187M contract; and much more...
June 13, 2006
Editor's Corner
June 11, 2006
Sanofi halts Ketek trial amid blistering warnings
June 8, 2006
FDA safety official called for halt to Ketek trial
June 7, 2006
SPOTLIGHT: FDA calls for Ketek warning
May 18, 2006
Ketek report spurs call for FDA reform
May 1, 2006
Ketek safety data, liver problems draw scrutiny
April 30, 2006
Sanofi's Ketek could cause liver problems
January 19, 2006

Paid Research Reports

More Research Reports >>